Article metrics
PDF
Other content recommended for you
- Weighing the risks of valproate in women who could become pregnant
- Impact of regulatory safety notices on valproate prescribing and pregnancy outcome among women of child-bearing potential in Scotland: a population-based cohort study
- Use of prescribing indicators as a means of identifying variation in the prevalence of valproate prescribing between health communities: a cross-sectional study
- Safety update: valproate safety and educational materials
- Trends in antiepileptic drug treatment and effectiveness in clinical practice in England from 2003 to 2016: a retrospective cohort study using electronic medical records
- Valproate pregnancy prevention scheme: what are the barriers to enrolling patients and how do we meet them?
- Restricting valproate prescribing in men: wisdom or folly?
- Epilepsies in children, young people, and adults: summary of updated NICE guidance
- Treating women with juvenile myoclonic epilepsy
- NICE guideline review: Epilepsies in children, young people and adults NG217